Clinical trial
Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in…
NCT00151723 · Radboud University Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00151723 |
|---|---|
| Title | Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism? |
| Official title | Subclinical Hyperthyroidism "To Treat or Not to Treat?" A Dutch Multicenter Trial |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Hyperthyroidism |
| Intervention type | Procedure |
| Interventions | treatment with 131I |
| Enrollment | 200 |
| Start date | Apr 1, 2004 |
| First posted | Sep 9, 2005 |
| Last update posted | Jul 18, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: